Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Long-term treatment recommended in breast cancer patients with severe radiation-induced fibrosis
March 2nd, 2006
Long-term treatment was recommended in breast cancer patients with severe radiation-induced fibrosis (RIF). "Significant regression of radiation (RT)-induced fibrosis has been achieved after treatment combining pentoxifylline (PTX) and alpha-tocopherol (vitE). In this study, we focus on the maximum response, how long it takes to achieve response, and changes after treatment discontinuation. Measurable superficial RIF was assessed in patients treated by RT for breast cancer in a long-treatment (24 to 48 months) PTX-vitE (LPE) group of 37 patients (47 RIFs) and in a short-treatment (6 to 12 months) PTX-vitE (SPE) group of 7 patients (8 RIFs)," scientists in France...
Source: Women's Health Weekly (2006-03-02)
|
